TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ: 200230)

TELCON RF PHARMACEUTICAL. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	71,549	97,673	110,233	255,964	517,387	404,261
Market Cap Growth	-34.91%	-11.39%	-56.93%	-50.53%	27.98%	-40.70%
Enterprise Value	104,889	107,951	136,288	323,257	529,065	411,692
Last Close Price	595.00	873.00	1015.00	2925.00	6060.00	4860.00
PE Ratio	-	8.52	-2.56	-11.12	-12.67	-7.26
PS Ratio	1.76	2.69	3.96	6.76	15.61	7.14
PB Ratio	0.78	0.93	1.31	2.40	5.66	3.57
P/FCF Ratio	-41.97	-19.71	-37.85	-97.97	309.62	99.68
P/OCF Ratio	30.29	-86.08	-52.67	-713.87	184.59	80.65
EV/Sales Ratio	2.71	2.97	4.90	8.54	15.96	7.27
EV/EBITDA Ratio	21.71	20.72	623.83	-890.34	229.33	55.80
EV/EBIT Ratio	302.53	111.83	-33.54	-70.84	-253.15	139.74
EV/FCF Ratio	-52.20	-21.79	-46.80	-123.73	316.61	101.51
Debt / Equity Ratio	0.43	0.26	0.36	0.52	0.97	0.11
Debt / EBITDA Ratio	8.54	5.26	138.58	-	38.28	1.65
Debt / FCF Ratio	-19.88	-5.54	-10.40	-21.41	52.85	3.00
Asset Turnover	0.27	0.28	0.19	0.21	0.21	0.36
Inventory Turnover	5.30	5.57	4.99	6.71	6.12	9.56
Quick Ratio	0.19	0.56	0.47	0.55	0.39	1.93
Current Ratio	0.34	0.94	0.67	0.62	0.44	2.23
Return on Equity (ROE)	-23.18%	14.75%	-44.16%	-23.10%	-40.73%	-40.93%
Return on Assets (ROA)	0.15%	0.46%	-1.77%	-1.62%	-0.83%	1.18%
Return on Capital (ROIC)	0.16%	0.49%	-1.83%	-1.67%	-0.86%	1.23%
Earnings Yield	-34.04%	14.24%	-38.18%	-9.02%	-7.90%	-13.56%
FCF Yield	-2.81%	-5.07%	-2.64%	-1.02%	0.32%	1.00%
Buyback Yield / Dilution	23.59%	-8.89%	-56.33%	-2.64%	-3.29%	-7.53%
Total Shareholder Return	23.59%	-8.89%	-56.33%	-2.64%	-3.29%	-7.53%

Source: S&P Capital IQ. Standard template. Financial Sources.